Independent neuroradiology governance: standards and clinical accountability

Radiology Prime provides an independent specialist neuroradiology second-opinion service on MRI and CT imaging of the brain, spine, and head and neck. All imaging is reviewed at full-resolution DICOM standard by our Clinical Lead, a consultant radiologist (Facharzt für Radiologie) with sub-specialty focus in neuroradiology and over ten years of senior experience, formerly Chief Resident in Neuroradiology at University Hospital Freiburg. Reports are prepared as an independent specialist radiology report to support discussion with your treating physician — not to replace the clinical judgement of the team responsible for your care.

Our clinical governance framework is built to promote responsible image review, consistent reporting, and clinical accountability across the platform’s six neuroradiology sub-capabilities.

1. Consultant eligibility and credential standards

Our Clinical Lead, and any additional sub-specialty reviewers added to the platform’s reviewing team as it grows, meet the following standards before undertaking any review:

• Licensed medical doctor with a recognised specialist radiology qualification valid within a regulated European medical or academic framework — such as Facharzt für Radiologie (Germany), FRCR (United Kingdom), or FMH Radiologie (Switzerland)
• Active registration with their national medical regulatory authority, currently confirmed in Germany. Additional country registrations are under verification and will be disclosed on the Clinical Lead & Medical Review page when confirmed.
• A minimum of ten years of senior-level radiology experience, with sub-specialty focus directly relevant to the content under review
• Active participation in multidisciplinary clinical discussions, including tumour boards where relevant
• Active professional standing within recognised European radiology organisations, including the European Society of Radiology (ESR)

Reviewer eligibility is assessed before engagement and reviewed periodically thereafter, in accordance with the standards set out in the Editorial Policy and the Medical Review Process.

2. Sub-specialty-matched review across the six neuroradiology sub-capabilities

Every case submitted for second-opinion review is allocated to a reviewer with sub-specialty expertise directly relevant to the clinical area of the imaging. Within the platform’s current scope, sub-specialty review covers the six neuroradiology sub-capabilities:

• Neuro-oncology — primary and metastatic tumours of the brain and spinal cord
• Demyelinating diseases — multiple sclerosis and related inflammatory CNS conditions
• Neurodegenerative diseases — dementia, white matter disease, and related conditions
• Congenital anomalies of the brain and spine — Chiari malformations, tethered cord, spinal dysraphism, and related developmental anomalies
• Head and neck imaging — tumour, trauma, and inflammatory pathology
• Vascular diseases of the head, neck, and spine — stroke, aneurysms, AVMs, and venous sinus thrombosis

The platform does not accept second-opinion cases outside specialist neuroradiology. Sub-specialty areas explicitly out of scope include musculoskeletal, urology and gynaecology, cardiothoracic, breast imaging, body oncology, and emergency presentations. Where a submitted case includes findings that fall outside our Clinical Lead’s direct sub-specialty scope, the case is declined or deferred — not reviewed under a general radiology framing.

3. Standardised clinical reporting

All radiology reports follow structured reporting principles consistent with internationally recognised neuroradiology frameworks. Where applicable, reports apply:

• McDonald criteria for multiple sclerosis diagnostic support
• RANO criteria for neuro-oncology response assessment
• Fazekas scoring for white matter disease
• MTA, GCA, and Koedam visual rating scales for neurodegenerative imaging
• NI-RADS for head and neck cancer post-treatment surveillance
• ASPECTS for acute ischaemic stroke imaging
• Spetzler-Martin grading for arteriovenous malformations
• MAGNIMS protocols for MS imaging

Reports are designed to describe objective imaging findings using shield-verb framing such as “features may be consistent with” and “findings raise the possibility of” rather than directive diagnostic language; provide differential considerations where clinically appropriate; cite the specific neuroradiology framework applied; and end with a consultative bridge to support discussion with the patient’s treating physician. Structured reporting enhances clarity, supports interdisciplinary communication, and reflects the consultative nature of the service.

The radiology report does not replace clinical examination, primary radiology reporting by the patient’s own imaging provider, or physician-led medical decision-making.

4. Full-resolution DICOM review

All imaging studies are reviewed at full diagnostic resolution using original DICOM datasets through certified medical viewing systems. Full-resolution DICOM review is treated as a non-negotiable governance standard rather than a service tier — a second opinion based on compressed or downsampled images would not meet the platform’s clinical accuracy threshold.

5. Quality assurance and professional oversight

The platform applies internal quality standards designed to promote consistency, accountability, and evidence alignment across all sub-specialty reviews. These include structured case allocation based on sub-specialty match, use of standardised report templates aligned with the neuroradiology frameworks named in section 3, defined documentation protocols, and periodic internal review of reporting processes against the four-stage review workflow described in the Medical Review Process.

Where a finding is clinically complex or where its interpretation depends on information not available within the case material submitted, the report indicates that the patient should discuss the findings with their treating physician for full clinical evaluation in the wider clinical context.

6. Continuing medical education standards

Our Clinical Lead, and any additional sub-specialty reviewers, maintain mandatory continuing medical education requirements within their licensing jurisdictions, participate in hospital-based clinical case review, and remain actively engaged with evolving European neuroradiology standards and guideline updates from the European Society of Radiology, the European Society of Neuroradiology, and the relevant national radiology societies of the platform’s Phase 1 markets.

Ongoing professional development supports alignment with current imaging practice and ensures that the radiology reports the platform delivers reflect contemporary sub-specialty standards.

7. Clinical scope and positioning

Radiology Prime provides an independent specialist neuroradiology radiology report on existing imaging studies. The report is informational and consultative, intended to support discussion with the patient’s treating physician.

The platform does not:

• Provide primary medical care
• Establish a doctor-patient relationship between our Clinical Lead and the patient
• Diagnose, prescribe, or direct treatment
• Replace the patient’s treating physician or treatment team
• Perform physical examinations
• Provide emergency or urgent care — emergency presentations are out of scope by design
• Offer first reads of unreported imaging — the service reviews studies that already have a primary radiology report from the patient’s own imaging provider

Clinical decisions should always be made in consultation with a qualified healthcare professional who has access to the patient’s full clinical context. Specialist neuroradiology second-opinion review is intended to support, not substitute for, comprehensive medical care.

8. Data protection and confidential handling

Clinical governance includes responsible data stewardship. The platform applies GDPR-aligned data protection principles throughout the case review workflow, secure encrypted transmission of imaging and clinical data, role-based separation of identifying and clinical data within the platform’s internal systems, and patient-directed deletion rights consistent with GDPR. Detailed information on data handling is set out in the Privacy Policy.

9. Editorial oversight

All medical and educational content published on this platform is reviewed and approved by our Clinical Lead before publication. As the platform’s reviewing radiologist and the sole sub-specialty neuroradiologist on the editorial team, our Clinical Lead carries final clinical responsibility for the accuracy and framing of every piece of clinical content the platform publishes. As the platform’s reviewing team grows, additional sub-specialty reviewers will be added to the editorial review process under the same standards.

Editorial review supports clinical accuracy, neutral and non-directive language, evidence-informed descriptions, avoidance of diagnostic overreach, responsible interpretation, transparent professional standards, patient clarity, and collaboration with the patient’s treating physician. The full editorial framework is described in the Editorial Policy and the four-stage clinical review workflow is described in the Medical Review Process.

All published educational content is provided for informational purposes only and is not intended as medical advice, diagnosis, or treatment. Clinical decisions should always be made in consultation with a qualified healthcare professional.ur governance commitment

Our governance commitmentmmitment

Radiology Prime provides independent specialist neuroradiology second opinions delivered by our Clinical Lead, a consultant radiologist with sub-specialty focus in neuroradiology and over ten years of senior experience. Every report is prepared at full-resolution DICOM standard, applies the established neuroradiology frameworks named in section 3, and is framed consultatively to support discussion with the patient’s treating physician.

Related Policies and Governance Documents